Domain | Measure | Screening/Enrollment | Pre-intervention | Post-intervention, Previsit | Post-visit | 2-week Follow-up | 6-week Follow-up | 12-week Follow-up |
---|---|---|---|---|---|---|---|---|
Demographics | Age, race, sex, education, marital status | X | Â | Â | Â | Â | Â | Â |
Average Pain | Numerical Analog Scale (0-10) | X | X | X | X | X | X | X |
Worst Pain | Numerical Analog Scale (0-10) | X | X | X | X | X | X | X |
Pain Severity | Mean of Average and Worst Pain | X | X | X | X | X | X | X |
Pain Impairment | MOS Pain Impairment Scale | X | X | Â | Â | X | X | X |
Anxiety | HADS Anxiety Subscale | X | Â | Â | Â | X | Â | X |
Functional Status and Well-being | SF-12 | X | Â | Â | Â | Â | X | Â |
Depression | PHQ-2 (not administered until Spring 2007) | X | Â | Â | Â | X | X | X |
Pain Beliefs | Brief Pain Barriers Questionnaire | Â | X | Â | Â | X | Â | Â |
Pain-Related Self-Efficacy | Derived from Anderson | X | X | X | X | X | X | X |
General Adherence | MOS General Adherence | X | Â | Â | Â | X | X | Â |
Communication Self-Efficacy | Maly | X | X | X | X | X | X | X |
Analgesic Therapy | Chart review | Â | Â | Â | X | Â | Â | Â |